Private Advisor Group’s Amneal Pharmaceuticals AMRX Stock Holding History

Private Advisor Group’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Buy	57,998 +24,759	+74%	+$339K	﹤0.01%	1374
2026 Q1	$413K	Sell	33,239 -4,546	-12%	-$61K	﹤0.01%	1984
2025 Q4	$476K	Buy	37,785 +10,967	+41%	+$125K	﹤0.01%	1848
2025 Q3	$268K	Hold	26,818	–	–	﹤0.01%	2153
2025 Q2	$217K	Hold	26,818	–	–	﹤0.01%	2180
2025 Q1	$225K	Sell	26,818 -90	-0.3%	-$751	﹤0.01%	2040
2024 Q4	$213K	Sell	26,908 -84	-0.3%	-$705	﹤0.01%	2057
2024 Q3	$225K	Sell	26,992 -25,200	-48%	-$197K	﹤0.01%	2139
2024 Q2	$331K	Hold	52,192	–	–	﹤0.01%	1815
2024 Q1	$316K	Sell	52,192 -7	-0%	-$39	﹤0.01%	1796
2023 Q4	$317K	Buy	52,199 +201	+0.4%	+$895	﹤0.01%	1748
2023 Q3	$219K	Buy	51,998 +52	+0.1%	+$194	﹤0.01%	1820
2023 Q2	$161K	Hold	51,946	–	–	﹤0.01%	1874
2023 Q1	$72.2K	Buy	51,946 +26,746	+106%	+$53.3K	﹤0.01%	1888
2022 Q4	$50	Buy	+25,200	New	+$56.5K	﹤0.01%	1620
2020 Q3	–	Sell	-2,012	Closed	-$10K	–	1640
2020 Q2	$10K	Buy	+2,012	New	+$8.29K	﹤0.01%	2912

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Private Advisor Group's AMRX Position: Q2 2026 in Review

Private Advisor Group increased its Amneal Pharmaceuticals (AMRX) stake by 74% in Q2 2026, buying an estimated $339K and bringing the position to 57,998 shares worth $1M. The position accounts for ﹤0.01% of the portfolio, ranked #1374.

Private Advisor Group first reported a position in AMRX in Q2 2020 and has held it in 16 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Private Advisor Group held 57,998 shares of Amneal Pharmaceuticals worth $1M as of Q2 2026.
Private Advisor Group bought 24,759 Amneal Pharmaceuticals shares in Q2 2026, an estimated $339K.
Amneal Pharmaceuticals made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1374 holding.
Private Advisor Group first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 16 quarters since.
310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.